Why Invest in a Gynaecology PCD Pharma Franchise: Opportunities and Challenges

The Indian pharma market is estimated to reach a phenomenal $130 billion by 2030 with speciality areas like gynaecology inducted with huge growth. According to the forecast, the gynaecology drug market in India is going to grow at 8.3% CAGR during 2022-2027, at least by 2024. Increased focus on women's reproductive health, higher awareness of diseases affecting women, and government focus on healthcare programs for women are considered the drivers for the growth of this market. Along with these, increasing infertility problems, hormonal disorders, health issues related to women's menstrual cycles, and health issues of mothers have augmented the demand for gynaecological products. According to reports, about 15% of Indian couples suffer from problems of infertility; hence, there is a high requirement for gynaecological products such as fertility medicines and hormonal drugs. To cater to these requirements Gynofert offers its Gynae PCD Pharma Franchise in India . Let’s discuss ...